Longevity & AgingNew Obesity Drug Burns Fat Without Cutting Appetite or Muscle
A UK biotech called MitoRx Therapeutics has unveiled preclinical data on MTRX31, a drug that fights obesity by fixing how mitochondria process energy rather than suppressing hunger. In a mouse study, MTRX31 cut body weight by 38% and fat mass by 62% over two months — without reducing food intake. Crucially, the mice retained muscle mass and showed improved strength alongside better blood sugar, insulin sensitivity, and blood lipid levels. The drug also reduced ectopic fat, the dangerous fat that builds up inside organs like the liver and pancreas. When combined with tirzepatide, weight loss exceeded 50%. These results suggest a fundamentally different approach to obesity treatment, one that targets metabolic efficiency rather than appetite, with potential implications for healthy aging and metabolic disease prevention.
